Exchange: NASDAQ·Updated 12:55 PM EDT
OCUL logo

OCUL Ocular Therapeutix Inc

$10.79
$0.115
(1.05%)
Today
EarningsNov 4
Mkt Cap$2.39B
Vol447,152.00

About OCUL

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.
36

Bearish Sentiment

How do you feel about OCUL?

Advertisement|Remove ads.